ABBOTT INDIA LIMITED
- Country
- ๐ฎ๐ณIndia
- Ownership
- Private
- Established
- 1888-01-01
- Employees
- 73K
- Market Cap
- $7.5B
- Website
- http://www.abbott.com
Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure
- Conditions
- First Posted Date
- 2002-06-04
- Last Posted Date
- 2006-08-15
- Lead Sponsor
- Abbott
- Target Recruit Count
- 200
- Registration Number
- NCT00038662
- Locations
- ๐บ๐ธ
Carolinas Medical Centre, Charlotte,, North Carolina, United States
๐บ๐ธUrologic Specialists Of Oklahoma, Inc., Tulsa,, Oklahoma, United States
๐บ๐ธCenter for Urologic Care, West Reading, Pennsylvania, United States
A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors
- Conditions
- First Posted Date
- 2002-06-04
- Last Posted Date
- 2006-08-15
- Lead Sponsor
- Abbott
- Target Recruit Count
- 36
- Registration Number
- NCT00038636
- Locations
- ๐ช๐ธ
Hospital Clinico de Barcelona, Barcelona, Spain
๐ช๐ธCiutat Sanitaria de Bellvitge, Barcelona, Spain
๐บ๐ธJohns Hopkins Hospital, Baltimore, Maryland, United States
Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor
- Conditions
- First Posted Date
- 2002-06-03
- Last Posted Date
- 2006-07-28
- Lead Sponsor
- Abbott
- Target Recruit Count
- 16
- Registration Number
- NCT00038519
- Locations
- ๐จ๐ฆ
Toronto General Hospital Division of The University Health Network, Toronto, Ontario, Canada
๐จ๐ฆPhillip Sestak, M.D, Vancouver, British Columbia, Canada
๐ต๐ฑWojewodzki Szpital Zakazny, Warszawa, Poland
Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART
- Conditions
- First Posted Date
- 2002-06-03
- Last Posted Date
- 2008-04-01
- Lead Sponsor
- Abbott
- Target Recruit Count
- 24
- Registration Number
- NCT00038532
- Locations
- ๐จ๐ฆ
Toronto General Hospital Division of The University Health Network, Toronto, Ontario, Canada
๐บ๐ธUniversity of Cincinnati Medical Center, Cincinnati, Ohio, United States
๐บ๐ธDiversified Medical Practices, P.A., Houston, Texas, United States
Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected Patients
- Conditions
- First Posted Date
- 2002-05-30
- Last Posted Date
- 2006-07-27
- Lead Sponsor
- Abbott
- Target Recruit Count
- 40
- Registration Number
- NCT00038220
- Locations
- ๐บ๐ธ
Aaron Diamond AIDS Research Center - Rockefeller University, New York, New York, United States
A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer
- Conditions
- First Posted Date
- 2002-05-13
- Last Posted Date
- 2006-08-15
- Lead Sponsor
- Abbott
- Target Recruit Count
- 1000
- Registration Number
- NCT00036543
- Locations
- ๐จ๐ฆ
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
๐บ๐ธAlaska Clinical Research Center, LLC, Anchorage, Alaska, United States
๐บ๐ธClinical Physiology Associates, Fort Myers, Florida, United States
Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer
- Conditions
- First Posted Date
- 2002-05-13
- Last Posted Date
- 2007-08-15
- Lead Sponsor
- Abbott
- Target Recruit Count
- 941
- Registration Number
- NCT00036556
- Locations
- ๐บ๐ธ
Ntouch Research Corporation, Dallas, Texas, United States
๐จ๐ฆPrincess Margaret Hospital, Toronto, Ontario, Canada
๐บ๐ธUCLA School of Medicine, Los Angeles, California, United States
The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDS
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2015-01-16
- Lead Sponsor
- Abbott
- Registration Number
- NCT00002331
- Locations
- ๐บ๐ธ
George Washington Univ Med Ctr, Washington, District of Columbia, United States
๐บ๐ธDr Margaret Fischel, Miami, Florida, United States
๐บ๐ธKaiser Permanente Med Ctr, San Francisco, California, United States
The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2009-02-20
- Lead Sponsor
- Abbott
- Registration Number
- NCT00002366
- Locations
- ๐ฆ๐บ
Saint Vincent's Hosp Med Centre, Sydney, Australia
๐ฆ๐บPrince Henry's Hosp / Med Oncology, Sydney, Australia
Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2009-02-20
- Lead Sponsor
- Abbott
- Registration Number
- NCT00002029
- Locations
- ๐บ๐ธ
Intracare Inc, Miami, Florida, United States
๐บ๐ธEast Orange Veterans Administration Med Ctr, East Orange, New Jersey, United States